Fig. 2

Effect of crude polysaccharide (CDDP) on: A Body weights (g), B Food Consumption (g) and C Water Intake (ml) of STZ-induced T1DM mice measured once in a week for 4-weeks during oral administration of CDDP treatment. Model group showed reduced body weights and increased food/water intake when compared to control group. Mice receiving CDDP doses and metformin via oral route had significantly elevated the body weights and reduced the consumption of food and intake of water in comparison with model group. Data were represented as Means ± SEM (n = 10), evaluated by one-way ANOVA by Tukey’s Multiple Comparison Test. Control group (normal healthy control), model group (STZ-induced T1DM), metformin group (200 mg/kg body weight), DDP-Low: low dose of CDDP (200 mg/kg body weight), DDP-Med: medium dose of CDDP (400 mg/kg body weight) and DDP-High: high dose of CDDP (600 mg/kg body weight). # p < 0.05, ## p < 0.01 ### p < 0.001 and #### p < 0.0001, model group compared with control group * p < 0.05, ** p < 0.01 and *** p < 0.001, CDDP and metformin treatment groups compared with model group